Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections

Emerg Infect Dis. 2021 May;27(5):1309-1316. doi: 10.3201/eid2705.203428.

Abstract

Streptococcus halichoeri is a relatively newly identified species of pyogenic streptococci that causes zoonotic infection in humans. S. halichoeri was first described in 2004 as indigenous to seals, and only 8 reports of human S. halichoeri infection have been published. S. halichoeri grows as small, white, nonhemolytic colonies and may be strongly catalase-positive on routine blood agar media, which can lead to isolates being misidentified as coagulase-negative staphylococci. S. halichoeri tests positive for Lancefield group B antigen, like S. agalactiae, but can be identified with matrix-assisted laser desorption/ionization time of flight mass spectrometry or partial 16S rRNA sequencing. We describe 3 cases of S. halichoeri bone and joint infections in patients in the United States with underlying health conditions. In addition, we examine the microbiologic characteristics of S. halichoeri and discuss the importance of fully identifying this organism that might otherwise be disregarded as a skin commensal.

Keywords: Streptococcus halichoeri; antimicrobial resistance; bacteria; grey seals; streptococci; underlying health conditions; zoonoses.

Publication types

  • Review

MeSH terms

  • Humans
  • Laboratories*
  • RNA, Ribosomal, 16S
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Streptococcal Infections*
  • Streptococcus / genetics

Substances

  • RNA, Ribosomal, 16S

Supplementary concepts

  • Streptococcus halichoeri